Acute Pancreatitis From Anaesthetist Point of View: Comments to the Russian Guidelines for the Treatment of Acute Pancreatitis

Yu.P. Orlov, N.V. Govorova, A.V. Glushchenko, A.V. Kolyadko, Yu.A. Nochnaya

Omsk State Medical University, Omsk

For correspondence: Orlov Yuriy Petrovich — Doctor of Medical Science, Professor at the Department of Anesthesiology and Intensive Care Omsk State Medical University, Omsk; e-mail: orlov-up@mail.ru

For citation: Orlov YuP, Govorova NV, Glushchenko AV, Kolyadko AV, Nochnaya YuA. Acute Pancreatitis from Anaesthesiologist-reanimatologist Point of View: Comments to the Russian Guidelines for the Treatment of Acute Pancreatitis. Intensive Care Herald. 2016;4:34–40.


The article is a commentary on the new Russian clinical guidelines for the treatment of acute pancreatitis. The article also presents data from foreign guidelines, where is uniquely positioned refusal of inhibiting the secretion of the pancreas, such as octreotide, which is confirmed by numerous literature data. The article highlights the most relevant areas of intensive care of acute pancreatitis (cautious and low-volume infusion therapy, monitoring of intra-abdominal pressure, abdominal compartment syndrome treatment strategy and nutritional support on the basis of early enteral nutrition). The article is an invitation to debate on the topic of intensive therapy of acute pancreatitis, the actual pathology, not only for surgeons, but also for the anesthesiologists.

Keywords: acute pancreatitis, octreotide, abdominal hypertension, review

Received: 23.11.2016


References

  1. Александрова И.В., Ильинский М.Е., Рей С.И. и др. Интенсивная терапия тяжелого острого панкреатита (обзор зарубежной литературы). Журнал им. Н.В. Склифосовского Неотложная медицинская помощь. 2012; 4: 34–43. [Aleksandrova I.V., Il’inskiy M.E., Rey S.I. et al. Intensive care of severe acute pancreatitis (review of foreign literature). Zhurnal im. N.V. Sklifosovskogo Neotlozhnaya meditsinskaya pomoshch’. 2012; 4: 34–43. (In Russ)]
  2. Вахрушев Я.М., Кропачева Н.С. Лечение билиарнозависимого панкреатита после холецистэктомии у больных желчнокаменной болезнью. Экспериментальная и клиническая гастроэнтерология. 2010; 8: 42–45. [Vakhrushev Ya.M., Kropacheva N.S. Treatment of Biliary pancreatitis after cholecystectomy in patients with cholelithiasis. Eksperimental’naya i klinicheskaya gastroenterologiya. 2010; 8: 42–45. (In Russ)]
  3. Колотушкин И.А., Балныков С.И. Оценка влияния октреотида на летальность у больных с изначально тяжелым течением панкреонекроза. Современные проблемы науки и образования. 2014; 5: 470. [Kolotushkin I.A., Balnykov S.I. Assessing the impact of octreotide on mortality in patients with initially severe necrotizing pancreatitis. Sovremennye problemy nauki i obrazovaniya. 2014; 5: 470. (In Russ)]
  4. Колотушкин И.А., Балныков С.И., Шубин Л.Б. Оценка роли октреотида в лечении панкреонекроза (с комментарием). Хирургия. Журнал им. Н.И. Пирогова. 2015; 6: 21–25. [Kolotushkin I.A., Balnykov S.I., Shubin L.B. Assessing the role of octreotide in the treatment of pancreatic necrosis (with commentary). Khirurgiya. Zhurnal im. N.I. Pirogova. 2015; 6: 21–25. (In Russ)]
  5. Стяжкина С.Н., Асоскова А.А., Плотникова Е.М. Клинический случай асептического панкреонекроза в результате рецидива панкреатита. Научный журнал. 2016; 11(12): 78–79. [Styazhkina S.N., Asoskova A.A., Plotnikova E.M. Case aseptic pancreatic necrosis as a result of recurrent pancreatitis. Nauchnyy zhurnal. 2016; 11(12): 78–79. (In Russ)]
  6. Проценко С.И., Вискунов В.Г., Федоренко В.Н. применение октреотида при лечении острого геморрагического панкреонекроза и его новые эффекты. Бюллетень СО РАМН. 2010; 5: 40–45. [Protsenko S.I., Viskunov V.G., Fedorenko V.N. The use of octreotide in the treatment of acute hemorrhagic necrotizing pancreatitis and its new effects. Byulleten’ SO RAMN. 2010; 5: 40–45. (In Russ)]
  7. Диагностика и лечение острого панкреатита. Российские клинические рекомендации. URL: http://nmo-roh.ru/images/metodiki/surg_school_2015_02_pw07_interactive.pdf. [Diagnosis and treatment of acute pancreatitis. Russian clinical guidelines. URL: http://nmo-roh.ru/images/metodiki/surg_school_2015_02_pw07_interactive.pdf. (In Russ)]
  8. IAP/APA evidence-based guidelines for the management of acute pancreatitis. Working Group IAP/APA (International Association of Pancreatology (American Pancreatic Association) Acute Pancreatitis Guidelines. 2013; 13: 1–15.
  9. Kirkpatrick A.W., Roberts D.J., De W.J. et al. Intra-abdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome. Intensive Care Med. 2013; 17: 1190–1206.
  10. Zhao K., Adam S.Z., Keswani R.N., Horowitz J.M., Miller F.H. Acute Pancreatitis Revised Atlanta Classification and the Role of Cross-Sectional Imaging. American Journal of Roentgenology. 2015; 205: 32–41.
  11. Sah R.P., Saluja А. Molecular mechanisms of pancreatic injury. Curr. Opin. Gastroenterol. 2012; 28(5): 507–515.
  12. Greenberg J.A., Hsu J., Bawazeer М. et al. Clinical practice guideline: management of acute pancreatitis. Can. J. Surg. 2016; 59(2): 128–140.
  13. Kemmer T.P., Malferteiner P., Buchler M. et al. Inhibition of human exocrine pancreatic secretion by the long-acting somatostatin analogue octreotide (SMS 201–995). Pharmacol. Ther. 1992; 6: 41–50.
  14. Хендерсон Дж.М. Патофизиология органов пищеварения. М.: Бином; СПб.: Невский диалект, 1999. [Khenderson J.M. Pathophysiology of the digestive system. M.: Binom; SPb.: Nevsky Dialect, 1999. (In Russ)]
  15. Leese T., Holliday M., Watkins M. et al. A multicentre controlled clinical trial of high-volume fresh frozen plasma therapy in prognostically severe acute pancreatitis. R. Coll. Surg. Engl. 1991; 73: 207–214.
  16. Trapnell J.E., Rigby C.C., Talbot C.H., Duncan E.H. A controlled trial of Trasylol in the treatment of acute pancreatitis. J. Surg. 1974; 61: 177–182.
  17. Imrie C.W., Benjamin I.S., Ferguson J.C. et al. A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis. J. Surg. 1978; 65: 337–341.
  18. Бобров О.Е., Мендель Н.А. Мифы панкреотологии: соматостатин и октреотид при остром панкреатите. Хирургия Украины. 2007; 1(21): 85–92. [Bobrov O.E., Mendel’ N.A. Myths pankreotologii: somatostatin and octreotide in acute pancreatitis. Khirurgiya Ukrainy. 2007; 1(21): 85–92. (In Russ)]
  19. Nathens A.B., Curtis J.R., Beale R.J. Management of the critically ill patient with severe acute pancreatitis. Care. Med. 2004; 32(12): 2524–2536.
  20. Foitzik T., Gock M., Schramm C. et al. Octreotide hardens the pancreas. Langenbecks Arch. 2006; 391(2): 108–112.
  21. Phillip V., Steiner J.M., Algul H. Early phase of acute pancreatitis: Assessment and management. World J. Gastrointest. Pathophysiol. 2014; 5(3): 158–168.
  22. Ranson J.H., Rifkind K.M., Roses D.F. et al. Prognostic signs and the role of operative management in acute pancreatitis. Surg. Gynecol. Obstet. 1974; 139: 69–81.
  23. Gravante G., Garcea G., Ong S.L. et al. Prediction of mortality in acute pancreatitis: a systematic review of the published evidence. 2009; 9: 601–614.
  24. Wu B.U., Johannes R.S., Sun X. et al. The early prediction of mortality in acute pancreatitis: a large population-based study. 2008; 5(7): 698–1703.
  25. Li J.Y., Yu T., Chen G.C., Yuan Y.H. et al. Enteral nutrition within 48 hours of admission improves clinical outcomes of acute pancreatitis by reducing complications: a meta-analysis. PLoS One. 2013; 8: e64926. URL: https://www.ncbi.nlm.nih.gov/pubmed/?term=PLoS+One.+2013%3B+8%3A+e64926.
  26. Levy P., Hastier P., Arotcarena R. et al. Efficacy of lanreotide 30 mg on prevention of pain relapse after oral refeeding in patients with necrotizing acute pancreatitis. A phase II prospective multicentre study. 2004; 4(3–4): 229–232.
  27. Масловский Л.В., Букшук А.А., Минушкин О.Н. Место синтетических аналогов соматостатина в лечении больных воспалительными заболеваниями поджелудочной железы. Кремлевская медицина. Клинический вестник. 2011; 3: 101–105. [Maslovskiy L.V., Bukshuk A.A., Minushkin O.N. Place of synthetic somatostatin analogues in the treatment of inflammatory diseases of the pancreas. Kremlevskaya meditsina. Klinicheskiy vestnik. 2011; 3: 101–105. (In Russ)]
  28. Компендиум 2004 — лекарственные препараты. Под ред. В.Н.Коваленко, А.П. Викторова. Киев: Морион, 2004. [Compendium 2004 — drugs. Eds.: V.N. Kovalenko, A.P. Viktorov. Kiev: Morion, 2004. (In Russ)]
  29. Malbrain M.L., Marik P.E., Witters I. et al. Fluid overload, de-resuscitation, and outcomes in critically ill or injured patients: a systematic review with suggestions for clinical practice. Anaesthesiology Intensive Therapy 2014; 46(5): 361–380.
  30. Mao E.Q., Fei J., Peng Y.B. et al. Rapid hemodilution is associated with increased sepsis and mortality among patients with severe acute pancreatitis. Chin. Med. J. 2010; 123: 1639–1644.
  31. Eckerwall G., Olin H., Andersson B., Andersson R. Fluid resuscitation and nutritional support during severe acute pancreatitis in the past: what have we learned and how can we do better? Clinical Nutrition. 2006; 25: 497–504.
  32. Jacob M., Chappell D., Rehm M. The ‘third space’ — fact or fiction? Best Pract. Res. Clin. Anaesthesiol. 2009; 23(2): 145–157.
  33. Janisch N., Gardnera T. Recent Advances in Managing Acute Pancreatitis. F1000Res. 2015; 4: F1000 Faculty Rev-1474. URL: https://www.ncbi.nlm.nih.gov/pubmed/26918139.
  34. Monnet X., Teboul J.-L. Assessment of volume responsiveness during mechanical ventilation: recent advances. Critical Care. 2013; 17(2): 217. URL: https://www.ncbi.nlm.nih.gov/pubmed/?term=Assessment+of+volume+responsiveness+during+mechanical+ventilation%3A+recent+advances.
  35. Jozwiak M., Silva S., Persichini R. et al. Extravascular lung water is an independent prognostic factor in patients with acute respiratory distress syndrome. Critical Care Medicine. 2013; 41(2): 472–480.
  36. Acheampong A., Vincent J. A positive fluid balance is an independent prognostic factor in patients with sepsis. Critical Care. 2015; 19: 251. URL: https://www.ncbi.nlm.nih.gov/pubmed/26073560.
  37. Villatoro E., Mulla M., Larvin M. Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database Syst. Rev. 2010; 5: CD002941.
  38. Jiang K., Huang W., Yang X.N. et al. Present and future of prophylactic antibiotics for severe acute pancreatitis. World J. Gas 2012; 18: 279–284.
  39. Murtaza G., Pal K.M., Jajja M.R. et al. Intra abdominal hypertension; incidence, prevalence and outcomes in a mixed intensive care unit: Prospective cohort study. Int. J. Surg. 2015; 19: 67–71.
  40. Malbrain M.L., Cheatham M.L., Kirkpatrick A. et al. Results from the international conference of experts on intra-abdominal hypertension and abdominal compartment syndrome. definitions. Intensive Care Med. 2006; 17: 1722–1732.
  41. Ball C.G., Kirkpatrick A.W. Intra-abdominal hypertension and the abdominal compartment syndrome. Scand. J. 2007; 17: 197–204.
  42. Souza G.D., Souza L.R., Cuenca R.M. et al. Understanding the international consensus for acute pancreatitis: classification of Atlanta 2012. Arq. Bras. Dig. 2016; 29(3): 206–210.
  43. Пирогов Н.И. Вопросы жизни. Дневник старого врача. М.: АСТ, 2013. [Pirogov N.I. Questions of life. The old doctor’s diary. Moscow: AST, 2013.]